These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3034406)

  • 1. Growth-related elevations of DNA topoisomerase II levels found in Dunning R3327 rat prostatic adenocarcinomas.
    Nelson WG; Cho KR; Hsiang YH; Liu LF; Coffey DS
    Cancer Res; 1987 Jun; 47(12):3246-50. PubMed ID: 3034406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural aspects of mammalian DNA replication: topoisomerase II.
    Nelson WG; Coffey DS
    NCI Monogr; 1987; (4):23-9. PubMed ID: 2819726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with an animal model for the study of prostatic carcinoma.
    Lubaroff DM; Culp DA
    Trans Am Assoc Genitourin Surg; 1977; 69():72-7. PubMed ID: 617916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Castration induces apoptosis in the ventral prostate but not in an androgen-sensitive prostatic adenocarcinoma in the rat.
    Brändström A; Westin P; Bergh A; Cajander S; Damber JE
    Cancer Res; 1994 Jul; 54(13):3594-601. PubMed ID: 8012987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A high-fat diet does not influence the growth of the Dunning R3327-H transplantable prostate adenocarcinoma.
    Schwab ED; Normolle D; Pacis RA; Cho SS; Pienta KJ
    Anticancer Res; 1998; 18(5A):3603-7. PubMed ID: 9858946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoregulatory markers in rats carrying Dunning R3327 H, G, or MAT-LyLu prostatic adenocarcinoma variants.
    Rubenstein M; Shaw MW; McKiel CF; Ray PS; Guinan PD
    Cancer Res; 1987 Jan; 47(1):178-82. PubMed ID: 3491674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric analysis of R3327 rat prostate adenocarcinoma grown in vivo and in vitro.
    Claflin AJ; Pollack A; Malinin T; Block NL; Irvin GL
    J Natl Cancer Inst; 1982 Jul; 69(1):79-87. PubMed ID: 6954325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of transforming growth factor-beta 1 in rat ventral prostate and Dunning R3327 PAP prostate tumor after castration and estrogen treatment.
    Lindström P; Bergh A; Holm I; Damber JE
    Prostate; 1996 Oct; 29(4):209-18. PubMed ID: 8876704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncodevelopmental enzymes of the Dunning rat prostatic adenocarcinoma.
    Hall M; Silverman L; Wenger AS; Mickey DD
    Cancer Res; 1985 Sep; 45(9):4053-9. PubMed ID: 2992772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical study of DNA topoisomerase II in human gastric disorders.
    Yabuki N; Sasano H; Kato K; Ohara S; Toyota T; Nagura H; Miyaike M; Nozaki N; Kikuchi A
    Am J Pathol; 1996 Sep; 149(3):997-1007. PubMed ID: 8780403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor progression in serial passages of the Dunning R3327-G rat prostatic adenocarcinoma: growth rate response to endocrine manipulation.
    Pollack A; Block NL; Stover BJ; Irvin GL
    Cancer Res; 1985 Mar; 45(3):1052-7. PubMed ID: 3971360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of protein kinase C isozyme messenger RNAs in dunning R-3327 rat prostatic tumors.
    Powell CT; Fair WR; Heston WD
    Cell Growth Differ; 1994 Feb; 5(2):143-9. PubMed ID: 8180127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actin filament organization of the Dunning R3327 rat prostatic adenocarcinoma system: correlation with metastatic potential.
    Zachary JM; Cleveland G; Kwock L; Lawrence T; Weissman RM; Nabell L; Fried FA; Staab EV; Risinger MA; Lin S
    Cancer Res; 1986 Feb; 46(2):926-32. PubMed ID: 3940653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system.
    Getzenberg RH; Light BW; Lapco PE; Konety BR; Nangia AK; Acierno JS; Dhir R; Shurin Z; Day RS; Trump DL; Johnson CS
    Urology; 1997 Dec; 50(6):999-1006. PubMed ID: 9426741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topoisomerase II-alpha expression increases with increasing Gleason score and with hormone insensitivity in prostate carcinoma.
    Hughes C; Murphy A; Martin C; Fox E; Ring M; Sheils O; Loftus B; O'Leary J
    J Clin Pathol; 2006 Jul; 59(7):721-4. PubMed ID: 16556661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human prostatic inhibin suppresses tumor growth and inhibits clonogenic cell survival of a model prostatic adenocarcinoma, the Dunning R3327G rat tumor.
    Lokeshwar BL; Hurkadli KS; Sheth AR; Block NL
    Cancer Res; 1993 Oct; 53(20):4855-9. PubMed ID: 8402673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo transfection of plasmid DNA in the Dunning prostate tumor R3327-AT1 is enhanced by focused ultrasound.
    Huber PE; Pfisterer P
    Gene Ther; 2000 Sep; 7(17):1516-25. PubMed ID: 11001372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of glyceraldehyde-3-phosphate dehydrogenase expression with cell motility and metastatic potential of rat prostatic adenocarcinoma.
    Epner DE; Partin AW; Schalken JA; Isaacs JT; Coffey DS
    Cancer Res; 1993 May; 53(9):1995-7. PubMed ID: 8481901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. R3327 prostate adenocarcinoma clonogenic cells: epithelial properties and hormone response.
    Dibner JJ; Nakeff A
    J Natl Cancer Inst; 1983 Jun; 70(6):1057-66. PubMed ID: 6574275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevation of topoisomerase I messenger RNA, protein, and catalytic activity in human tumors: demonstration of tumor-type specificity and implications for cancer chemotherapy.
    Husain I; Mohler JL; Seigler HF; Besterman JM
    Cancer Res; 1994 Jan; 54(2):539-46. PubMed ID: 8275492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.